Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Regulatory News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

Share Price is delayed by 15 minutes
Get Live Data
6.35    0.20 (3.25%)
Bid:
6.20
Ask:
6.50
Spread: 0.30 (4.839%)
Market Cap: £6.56m
OPTI Live PriceLast checked at - London Stock Exchange

Intraday OptiBiotix Health Share Chart

Product Approval

14 Sep 2012 11:30

RNS Number : 2972M
Ceres Media International PLC
14 September 2012
 



For release: 14 September 2012

 

 CERES MEDIA PRODUCTS APPROVED BY HEWLETT PACKARD FOR USE IN THEIR EXISTING AND NEW GENERATION DIGITAL PRINTERS

 

NATUREWOVEN™ CHORUS™ AND GOSSYP™ ALL APPROVED AFTER EXTENSIVE TRIALS

 

 

Ceres Media International plc ("Ceres Media") are pleased to announce that it's NatureWovenTM range of printing substrates have been tested and approved for use by Hewlett Packard Corporation in their existing and new generation of digital print machines. This approval includes upload of all technical details of the products and approved downloadable printer settings onto HP's media locator. This media locator allows any HP machine owner globally to search for approved materials and download relevant machine settings to allow optimal print performance.

 

Additionally, HP have included printed samples of NatureWovenTM ChorusTM in their current marketing initiatives and the materials are due to be showcased by HP at FESPA Mexico in September. This is the leading focused print exhibition in Central America and will display Ceres Media as front runner in the field of environmentally friendly materials for the print industry.

 

Commenting on the approval by HP, Alex Dowdeswell, CEO of Ceres Media International said: "It has taken a significant amount of time to complete the rigorous testing required by HP to gain their approval but this is an important step for the company and its product range. HP are one of the world's largest print machine manufacturers and approval by them ratifies the quality of our products and their ability to perform equally with traditional products that don't offer our green benefits. Inclusion by HP in its media locator will provide visibility of our products to a large number of printers in multiple countries and enable them to gain quick and easy access to the approved settings to print. This will eliminate the need for each printer to trial material."

 

For additional information please contact:

 

Alex Dowdeswell, CEO

Ceres Media +44 (0)7930 189 192

 

Cairn Financial Advisers

Liam Murray / Jo Turner +44 (0)20 7148 7900

 

 

XCap

Jon Bellis

 

Mike Wort / Anna Dunphy

De Facto Financial +44 (0)20 7556 1063

 

 

Notes to Editors:

Ceres Media is a specialist materials company producing natural biodegradable materials for the print industry. The company is dedicated to providing sustainable and compostable alternatives for the petroleum-based materials such as vinyl which are used extensively by the print industry for major corporations advertising their products. Petroleum- based materials such as vinyl do not degrade readily and have to be disposed of in landfill with an obvious negative impact on the environment. The materials that Ceres Media have developed have the same print quality as vinyl, do not require modifications to exiting printing machines in normal use and are cost competitive with respect to vinyl. These products can, however be composted once an advertising campaign has been completed and do not have any adverse impact on the environment. For technical information and details of how to purchase the range of products that Ceres Media produce for various advertising needs, please go to www.naturaladcampaign.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABGGDCIDBBGDS
Date   Source Headline
23rd Jun 20264:25 pmRNSResult of AGM
2nd Jun 20267:00 amRNS-RInvestor presentation and SweetBiotix® Sampling
29th May 20267:00 amRNSDirector/PDMR Shareholding
28th May 20267:00 amRNSFinal Results & Notice of AGM
14th May 20267:00 amRNS-RSweetBiotix® Sampling
5th May 20262:30 pmRNSHolding(s) in Company
1st May 202612:00 pmRNSPartial Disposal of Shares in SkinBioTherapeutics
1st Apr 20267:00 amRNSTrading Update
24th Feb 20267:00 amRNSWellBiome® clinical trial on surgical outcomes
17th Feb 20267:00 amRNSStatement: SkinBioTherapeutics Announcement
21st Jan 20267:00 amRNSLarge Order and Record Early Orders for 2026
20th Jan 20267:00 amRNS-RNew Investor Website
2nd Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 20267:00 amRNSHolding(s) in Company
24th Nov 20257:00 amRNSSweetBiotix Overview and Update
17th Nov 20257:00 amRNSOrder with well-known Weight Management Company
13th Oct 20253:31 pmRNSHolding(s) in Company
2nd Oct 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 202512:28 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSHalf-year Report
21st Aug 20257:00 amRNSAdmission to Trading on the OTCQB Venture Market
20th Aug 20257:00 amRNSAgreement with Weight Management Company
14th Aug 20257:00 amRNSLaunch of SlimBiome in leading US brand
6th Aug 20254:08 pmRNSResult of AGM
6th Aug 20257:00 amRNSIssue of Options
28th Jul 20257:00 amRNSTrading update
30th Jun 20257:00 amRNSChange of Broker
30th Jun 20257:00 amRNSFinal Results
11th Jun 20257:00 amRNS-RSlimBiome® study in European Journal of Nutrition
23rd May 20257:00 amRNSPlacing and Issue of Warrants
20th May 20257:00 amRNSLaunch of SlimBiome products with US partner
15th Apr 20257:00 amRNSFirst order from US weight management brand
7th Apr 20255:34 pmRNSHolding(s) in Company
18th Mar 20257:00 amRNSCommercial Update
18th Feb 20257:00 amRNSLaunch of Daily Nouri FeelFull product in America
20th Jan 20257:00 amRNS-RLaunch of products on Amazon India
8th Jan 20257:00 amRNSDirectorate Change
20th Dec 202412:00 pmRNSIssue of Options
12th Dec 20242:45 pmRNSHolding(s) in Company
3rd Dec 20247:00 amRNSLaunch of Dr Morepen LightLife in India
30th Oct 20247:00 amRNSRequisition update
25th Oct 20244:29 pmRNSHolding(s) in Company
24th Oct 20247:00 amRNSTotal Voting Rights
23rd Oct 20247:00 amRNSDirectorate Change
18th Oct 20247:00 amRNSResponse to Publication of Circular by ProBiotix
10th Oct 20247:00 amRNSSlimBiome study update
27th Sep 20247:00 amRNSHalf-year Report
26th Sep 20247:00 amRNSResponse to Probiotix Health requisition notice
5th Sep 202410:32 amRNSProBiotix Health plc Fundraise
20th Aug 20247:00 amRNSCommercial update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.